Department of Bone and Soft Tissue Tumors, Peking University Cancer Hospital, Associate Chief Physician, Doctor of Medicine 【Professional Expertise】 Specializes in comprehensive treatment and the formulation of surgical, chemotherapeutic, and radiotherapeutic plans for rhabdomyosarcoma, Ewing sarcoma, liposarcoma (including dedifferentiated liposarcoma and myxoid liposarcoma, etc.). Conducts in-depth research on alveolar soft part sarcoma, undifferentiated pleomorphic sarcoma, synovial sarcoma, epithelioid sarcoma, leiomyosarcoma, and other diseases, as well as the treatment of rare and distinctive conditions such as solitary fibrous tumor (SFT)/hemangiopericytoma, epithelioid hemangioendothelioma, angiosarcoma, and Kaposi sarcoma. 【Social Appointments (≤5 items)】 Member, Medication Treatment Group, Bone Tumor Professional Committee, Chinese Anti-Cancer Association; Member, Pediatric Tumor Professional Committee, Chinese Research Hospital Association; Member, Clinical Research Professional Committee, China Medical Education Association; Member, Bone and Soft Tissue Tumor Professional Committee, China Medical Education Association; Member, Haidian District Youth Federation, Beijing 【Talent Title/Academic Experience】 Visiting Scholar, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 【Representative Achievements】 Principal investigator of one project funded by the National Natural Science Foundation of China. Published multiple articles as first author in *Clinical Cancer Research* and *Bioactive Materials*.